glimepiride has been researched along with Disease Models, Animal in 11 studies
glimepiride: structure given in first source
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The study of xeroderma pigmentosum has yielded unforeseen advances regarding how defects in the nucleotide excision repair pathway result in this devastating disease, but development of therapeutic strategies has trailed behind the mechanistic discoveries." | 2.61 | Novel therapeutic approaches to xeroderma pigmentosum. ( Glass, DA; Weon, JL, 2019) |
| "Tauopathy is a group of neurodegenerative diseases in which the pathogenesis processes are related to tau protein." | 1.72 | Glimepiride mitigates tauopathy and neuroinflammation in P301S transgenic mice: role of AKT/GSK3β signaling. ( Azab, SS; El-Desouky, S; Elsherbiny, DA; Salama, M; Zaki, MO, 2022) |
| "To generate a mouse model of type 2 diabetes mellitus (DM), male C57BL/6J mice were fed with high-fat diet and injected with streptozotocin." | 1.51 | Specific PERK inhibitors enhanced glucose-stimulated insulin secretion in a mouse model of type 2 diabetes. ( Ham, DS; Jung, HS; Kim, JW; Kim, MJ; Kim, MN; Min, SH; Park, KS; Yoon, KH, 2019) |
| " The present study concludes that bioavailability of SIL increases when co-administered chronically with GLIM in the management of DN animals, and the mechanism is supported by molecular modeling studies." | 1.42 | Does glimepiride alter the pharmacokinetics of sildenafil citrate in diabetic nephropathy animals: investigating mechanism of interaction by molecular modeling studies. ( Chandewar, A; Mazumder, PM; Timiri, AK; Tripathi, AS, 2015) |
| "Hyperglycemia is the main feature for the diagnosis of this disease." | 1.40 | Persistent impaired glucose metabolism in a zebrafish hyperglycemia model. ( Antonioli, R; Bogo, MR; Bonan, CD; Capiotti, KM; Da Silva, RS; Kist, LW, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 5 (45.45) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Miura, M | 1 |
| Tanaka, S | 1 |
| Ikeda, M | 1 |
| Kawakami, J | 1 |
| Watanabe, H | 1 |
| Namiki, N | 1 |
| Uchida, S | 1 |
| Zaki, MO | 1 |
| El-Desouky, S | 1 |
| Elsherbiny, DA | 1 |
| Salama, M | 1 |
| Azab, SS | 1 |
| Oduola-Akande, MD | 1 |
| Ishola, IO | 1 |
| Olubodun-Obadun, TG | 1 |
| Akande, AJ | 1 |
| Adeyemi, OO | 1 |
| Nasreen, W | 1 |
| Sarker, S | 1 |
| Sufian, MA | 1 |
| Md Opo, FAD | 1 |
| Shahriar, M | 1 |
| Akhter, R | 1 |
| Halim, MA | 1 |
| Weon, JL | 1 |
| Glass, DA | 1 |
| Kim, MJ | 1 |
| Kim, MN | 1 |
| Min, SH | 1 |
| Ham, DS | 1 |
| Kim, JW | 1 |
| Yoon, KH | 1 |
| Park, KS | 1 |
| Jung, HS | 1 |
| Capiotti, KM | 1 |
| Antonioli, R | 1 |
| Kist, LW | 1 |
| Bogo, MR | 1 |
| Bonan, CD | 1 |
| Da Silva, RS | 1 |
| Tripathi, AS | 1 |
| Timiri, AK | 1 |
| Mazumder, PM | 1 |
| Chandewar, A | 1 |
| Ye, Y | 1 |
| Lin, Y | 1 |
| Perez-Polo, JR | 1 |
| Birnbaum, Y | 1 |
| Pan, J | 1 |
| Chan, EK | 1 |
| Yu, E | 1 |
| Chen, J | 1 |
| Schranz, V | 1 |
| Charles, MA | 1 |
1 review available for glimepiride and Disease Models, Animal
| Article | Year |
|---|---|
Novel therapeutic approaches to xeroderma pigmentosum.
Topics: Acetohexamide; Administration, Cutaneous; Animals; Caloric Restriction; Dermatology; Disease Models, | 2019 |
10 other studies available for glimepiride and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Increased plasma drug concentration and decreased additional insulin secretion following oral administration of glimepiride in Spontaneously Diabetic Torii rats.
Topics: Administration, Oral; Animals; Diabetes Mellitus, Type 2; Disease Models, Animal; Humans; Insulin Se | 2022 |
Glimepiride mitigates tauopathy and neuroinflammation in P301S transgenic mice: role of AKT/GSK3β signaling.
Topics: Animals; Caspase 3; Diabetes Mellitus, Type 2; Disease Models, Animal; Glycogen Synthase Kinase 3 be | 2022 |
Glimepiride Prevents 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Induced Dopamine Neurons Degeneration Through Attenuation of Glia Activation and Oxidative Stress in Mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Diabetes Mellitus, Type 2; Disease Models, An | 2023 |
A possible alternative therapy for type 2 diabetes using Myristica fragrans Houtt in combination with glimepiride: in vivo evaluation and in silico support.
Topics: Alloxan; Animals; Diabetes Mellitus, Type 2; Disease Models, Animal; Drug Therapy, Combination; Fema | 2020 |
Specific PERK inhibitors enhanced glucose-stimulated insulin secretion in a mouse model of type 2 diabetes.
Topics: Adenine; Animals; Diabetes Mellitus, Type 2; Disease Models, Animal; eIF-2 Kinase; Glucose; Hypergly | 2019 |
Persistent impaired glucose metabolism in a zebrafish hyperglycemia model.
Topics: Animals; Disease Models, Animal; Eye Proteins; Glucose; Glycosylation; Hyperglycemia; Hypoglycemic A | 2014 |
Does glimepiride alter the pharmacokinetics of sildenafil citrate in diabetic nephropathy animals: investigating mechanism of interaction by molecular modeling studies.
Topics: Animals; Blood Glucose; Cytochrome P-450 CYP2C9; Diabetic Nephropathies; Disease Models, Animal; Dru | 2015 |
Oral glyburide, but not glimepiride, blocks the infarct-size limiting effects of pioglitazone.
Topics: Administration, Oral; Animals; Body Weight; Coronary Vessels; Data Interpretation, Statistical; Deca | 2008 |
Prevention and cure of type 1 diabetes in the BB rat by islet allotransplantation and glimepiride treatment.
Topics: Animals; Diabetes Mellitus, Type 1; Disease Models, Animal; Immunosuppressive Agents; Islets of Lang | 1995 |